In primary lung cancer tissues, 44.2% (46/104) of tumor samples exhibited negative staining of the Fibulin 2 protein, and SCC samples displayed significantly higher expression of FBLN2 than ADC, indicating its potential diagnostic value for distinguishing lung SCC from ADC. This evidence concerns the gene FBLN2 and lung cancer.